Long-Term Effects of Safinamide on Mood Fluctuations in Parkinson's Disease

JAMA Neurol.

Schapira AH, Fox SH, Hauser RA, Jankovic J, Jost WH, Kenney C, Kulisevsky J, Pahwa R, Poewe W, Anand R

doi: 10.1001/jamaneurol.

Neurology.

Ferreira JJ, Lees AJ, Poewe W, Rascol O, Rocha JF, Keller B, Soares-da-Silva P

doi: 10.1212/WNL.

CNS Drugs.

Blair HA, Dhillon S

doi: 10.1007/s40263-017-0408-1.

Expert Opin Drug Metab Toxicol.

Müller T

doi: 10.1080/

Parkinson’s Disease

Acta Neurol Scand.

Avila A, Caballol N, Martín-Baranera M, Gómez-Ruiz I, Balagué-Marmaña M, Planas-Ballvé A, Cardona X

doi: 10.1111/ane.

Expert Opin Pharmacother.

Scott RM, Schapira A

doi: 10.1080/

Lancet Neurol.

Katzenschlager R, Poewe W, Rascol O, Trenkwalder C, Deuschl G, Chaudhuri KR, Henriksen T, van Laar T, Spivey K, Vel S, Staines H, Lees A

doi: 10.1016/S1474-

Multiple Sclerosis

doi: 10.1111/ene.13594.

Parkinson’s Disease

Lancet Neurol.

van der Kolk NM, de Vries NM, Kessels RPC, Joosten H, Zwinderman AH, Post B, Bloem BR

doi: 10.1016/S1474-4422(19)30285-6.

Related content